AltruBio Company
.jpg)
AltruBio is focused on developing targeted antibody therapeutics for the treatment of cancer and immune related inflammatory diseases.
Last Funding Date:
2021-04-15
Last Funding Type:
Series A
Industry:
Women Cancer Treatment
Founded Date:
2000-06-01
Total Funding:
$103 000 000
Headquarters:
Los Altos, California, United States
Estimated Revenue:
$10M to $50M
Funding Status:
Early Stage Venture